Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia